Merck & Co Inc
MRK: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|TZ | LOCK|$!# | LOCK|>N^SM& |
Merck Earnings: Steady Quarter, but Raising Our Forecast for Biggest Pipeline Opportunity
Merck reported 5% second-quarter revenue growth, and management narrowed and slightly raised its 2026 revenue guidance to $66.3 billion-$67.3 billion from $65.8 billion-$67 billion. Shares were up 1% in intraday trading on Aug. 4.
